Boston's latest $265m buy of ablation guidance firm gets lukewarm investor reception
This article was originally published in Clinica
Executive Summary
Boston Scientific has made its third acquisition of the year, agreeing to buy surgical navigation specialist Rhythmia Medical; however, some analysts were unimpressed with the firm's attempts to buy its way back to profitability.